Susanne M. Scesney

964 total citations
17 papers, 760 citations indexed

About

Susanne M. Scesney is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Susanne M. Scesney has authored 17 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Molecular Biology. Recurrent topics in Susanne M. Scesney's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Complement system in diseases (5 papers) and Glycosylation and Glycoproteins Research (2 papers). Susanne M. Scesney is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Complement system in diseases (5 papers) and Glycosylation and Glycoproteins Research (2 papers). Susanne M. Scesney collaborates with scholars based in United States, Switzerland and United Kingdom. Susanne M. Scesney's co-authors include Henry C. Marsh, Paul Sakorafas, Sahana Bose, Jochen Salfeld, Eric H. Sasso, Zehra Kaymakcalan, Gerald Carson, Pamella J. Ford, Savvas C. Makrides and Yoshifumi Naka and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Circulation Research.

In The Last Decade

Susanne M. Scesney

16 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susanne M. Scesney United States 14 405 201 189 124 105 17 760
A Rifai United States 18 325 0.8× 255 1.3× 208 1.1× 70 0.6× 103 1.0× 33 889
M Rosa United States 5 492 1.2× 232 1.2× 178 0.9× 71 0.6× 152 1.4× 5 989
Z. Mishal France 13 331 0.8× 171 0.9× 164 0.9× 111 0.9× 99 0.9× 23 765
Yutaka Kanamaru Japan 20 730 1.8× 444 2.2× 267 1.4× 80 0.6× 62 0.6× 31 1.4k
J L Smith United Kingdom 15 298 0.7× 116 0.6× 100 0.5× 62 0.5× 61 0.6× 42 682
Yoichi Tatsumi Japan 22 550 1.4× 255 1.3× 156 0.8× 58 0.5× 124 1.2× 74 1.2k
Dzung T. Le United States 11 230 0.6× 278 1.4× 99 0.5× 78 0.6× 339 3.2× 15 778
Stipo Jurčević United Kingdom 18 596 1.5× 218 1.1× 56 0.3× 268 2.2× 103 1.0× 47 1.1k
Arnold D. Rubin United States 17 245 0.6× 289 1.4× 157 0.8× 54 0.4× 115 1.1× 33 848
Z Awdeh United States 8 448 1.1× 110 0.5× 108 0.6× 100 0.8× 162 1.5× 14 726

Countries citing papers authored by Susanne M. Scesney

Since Specialization
Citations

This map shows the geographic impact of Susanne M. Scesney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanne M. Scesney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanne M. Scesney more than expected).

Fields of papers citing papers by Susanne M. Scesney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanne M. Scesney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanne M. Scesney. The network helps show where Susanne M. Scesney may publish in the future.

Co-authorship network of co-authors of Susanne M. Scesney

This figure shows the co-authorship network connecting the top 25 collaborators of Susanne M. Scesney. A scholar is included among the top collaborators of Susanne M. Scesney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanne M. Scesney. Susanne M. Scesney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bardwell, Philip D., Matthew Staron, Junjian Liu, et al.. (2017). Potent and conditional redirected T cell killing of tumor cells using Half DVD-Ig. Protein & Cell. 9(1). 121–129. 11 indexed citations
2.
Hossler, Patrick, David Ouellette, Alexander Ibraghimov, et al.. (2017). Arabinosylation of recombinant human immunoglobulin-based protein therapeutics. mAbs. 9(4). 715–734. 21 indexed citations
3.
Finco, Deborah, Christine Grimaldi, Madeline Fort, et al.. (2014). Cytokine release assays: Current practices and future directions. Cytokine. 66(2). 143–155. 64 indexed citations
4.
Scesney, Susanne M. & Alexander Ibraghimov. (2013). In vitro cytokine release assays for commercially available biologics for predicting cytokine storm in human patients (P6321). The Journal of Immunology. 190(Supplement_1). 184.22–184.22.
5.
Kaymakcalan, Zehra, Paul Sakorafas, Sahana Bose, et al.. (2009). Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor. Clinical Immunology. 131(2). 308–316. 248 indexed citations
6.
Wu, Chengbin, Paul Sakorafas, Renee Miller, et al.. (2003). IL-18 Receptor β-Induced Changes in the Presentation of IL-18 Binding Sites Affect Ligand Binding and Signal Transduction. The Journal of Immunology. 170(11). 5571–5577. 42 indexed citations
8.
Rittershaus, Charles W., Lawrence J. Thomas, David P. Miller, et al.. (1999). Recombinant Glycoproteins That Inhibit Complement Activation and Also Bind the Selectin Adhesion Molecules. Journal of Biological Chemistry. 274(16). 11237–11244. 43 indexed citations
9.
Naka, Yoshifumi, Henry C. Marsh, Susanne M. Scesney, Mehmet C. Öz, & David J. Pinsky. (1997). COMPLEMENT ACTIVATION AS A CAUSE FOR PRIMARY GRAFT FAILURE IN AN ISOGENEIC RAT MODEL OF HYPOTHERMIC LUNG PRESERVATION AND TRANSPLANTATION. Transplantation. 64(9). 1248–1255. 47 indexed citations
10.
Scesney, Susanne M., Savvas C. Makrides, Michael Gosselin, et al.. (1996). A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway. European Journal of Immunology. 26(8). 1729–1735. 28 indexed citations
11.
Candinas, Daniel, Simon C. Robson, T Miyatake, et al.. (1996). EFFECT OF REPETITIVE HIGH-DOSE TREATMENT WITH SOLUBLE COMPLEMENT RECEPTOR TYPE 1 AND COBRA VENOM FACTOR ON DISCORDANT XENOGRAFT SURVIVAL1,2. Transplantation. 62(3). 336–342. 49 indexed citations
12.
Kaufman, Teodoro S., et al.. (1995). Design, Synthesis, and Evaluation of A-, C-, and D-Ring Analogs of the Fungal Metabolite K-76 as Potential Complement Inhibitors. Journal of Medicinal Chemistry. 38(9). 1437–1445. 20 indexed citations
13.
14.
Rabinovici, Reuven, Jacob Levine, Jerome Vernick, et al.. (1994). Interleukin-2-induced lung injury. The role of complement.. Circulation Research. 74(2). 329–335. 21 indexed citations
15.
Makrides, Savvas C., Susanne M. Scesney, Pamella J. Ford, et al.. (1992). Cell surface expression of the C3b/C4b receptor (CR1) protects Chinese hamster ovary cells from lysis by human complement.. Journal of Biological Chemistry. 267(34). 24754–24761. 44 indexed citations
16.
Yeh, Chen‐Hao, Henry C. Marsh, Gerald Carson, et al.. (1991). Recombinant soluble human complement receptor type 1 inhibits inflammation in the reversed passive arthus reaction in rats. The Journal of Immunology. 146(1). 250–256. 79 indexed citations
17.
Andrews, Charla, John L. Sullivan, Doreen B. Brettler, et al.. (1987). Isolation of human immunodeficiency virus from hemophiliacs: Correlation with clinical symptoms and immunologic abnormalities. The Journal of Pediatrics. 111(5). 672–677. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026